BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30761473)

  • 1. Effects of Tec Tyrosine Kinase Inhibition on the Inflammatory Response of Severe Acute Pancreatitis-Associated Acute Lung Injury in Mice.
    Meng Y; Sha S; Yang J; Ren H
    Dig Dis Sci; 2019 Aug; 64(8):2167-2176. PubMed ID: 30761473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice.
    Qiao YY; Liu XQ; Xu CQ; Zhang Z; Xu HW
    World J Gastroenterol; 2016 Jun; 22(21):5023-32. PubMed ID: 27275094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
    Uckun FM; Vassilev A; Bartell S; Zheng Y; Mahajan S; Tibbles HE
    Leuk Lymphoma; 2003 Sep; 44(9):1569-77. PubMed ID: 14565661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of Tec kinase, LFM-A13, decreases pro-inflammatory mediators production in LPS-stimulated RAW264.7 macrophages via NF-κB pathway.
    Wang F; Zhang W; Wang C; Fang X; Cheng H; Liu S; Chen XL
    Oncotarget; 2017 May; 8(21):34099-34110. PubMed ID: 28415764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of non-receptor tyrosine kinase Tec in the production of pro-inflammatory cytokines from macrophages induced by endotoxin/lipopolysaccharide].
    Wang C; Wang F; Zhou B; Qiu L; Wang J; Liu S; Chen X
    Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):11-5. PubMed ID: 25876633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity.
    van den Akker E; van Dijk TB; Schmidt U; Felida L; Beug H; Löwenberg B; von Lindern M
    Biol Chem; 2004 May; 385(5):409-13. PubMed ID: 15196000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.
    Uckun FM; Zheng Y; Cetkovic-Cvrlje M; Vassilev A; Lisowski E; Waurzyniak B; Chen H; Carpenter R; Chen CL
    Clin Cancer Res; 2002 May; 8(5):1224-33. PubMed ID: 12006542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical toxicity and pharmacokinetics of the Bruton's tyrosine kinase-targeting anti-leukemic drug candidate, alpha-cyano-beta-hydroxy-beta-methyl-N- (2,5-dibromophenyl) propenamide (LFM-A13).
    Uckun FM; Tibbles H; Venkatachalam T; DuMez D; Erbeck D
    Arzneimittelforschung; 2007; 57(1):31-46. PubMed ID: 17341007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide].
    Mahajan S; Ghosh S; Sudbeck EA; Zheng Y; Downs S; Hupke M; Uckun FM
    J Biol Chem; 1999 Apr; 274(14):9587-99. PubMed ID: 10092645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling through CD16b in human neutrophils involves the Tec family of tyrosine kinases.
    Fernandes MJ; Lachance G; Paré G; Rollet-Labelle E; Naccache PH
    J Leukoc Biol; 2005 Aug; 78(2):524-32. PubMed ID: 15899983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of c-Jun N-terminal kinase signaling pathway on severe acute pancreatitis-associated lung injury.
    Liu M; Shi L; Chen M; Chen S; Zou X
    Pancreas; 2012 Apr; 41(3):358-66. PubMed ID: 22015972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor.
    Gilbert C; Levasseur S; Desaulniers P; Dusseault AA; Thibault N; Bourgoin SG; Naccache PH
    J Immunol; 2003 May; 170(10):5235-43. PubMed ID: 12734372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of penehyclidine hydrochloride on severe acute pancreatitis-associated acute lung injury in rats.
    Zhu R; Zhao Y; Li X; Bai T; Wang S; Wang W; Sun Y
    Biomed Pharmacother; 2018 Jan; 97():1689-1693. PubMed ID: 29793332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
    Cetkovic-Cvrlje M; Uckun FM
    Br J Haematol; 2004 Sep; 126(6):821-7. PubMed ID: 15352986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats.
    Wang L; Tu XH; Zhao P; Song JX; Zou ZD
    Mol Med Rep; 2012 Aug; 6(2):287-92. PubMed ID: 22613963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ω-3 fatty acids on toll-like receptor 4 and nuclear factor-κB p56 in lungs of rats with severe acute pancreatitis.
    Wang B; Wu XW; Guo MX; Li ML; Xu XB; Jin XX; Zhang XH
    World J Gastroenterol; 2016 Nov; 22(44):9784-9793. PubMed ID: 27956802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).
    Uckun FM; Dibirdik I; Qazi S; Vassilev A; Ma H; Mao C; Benyumov A; Emami KH
    Bioorg Med Chem; 2007 Jan; 15(2):800-14. PubMed ID: 17098432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase signalling regulates trypsinogen activation and tissue damage in severe acute pancreatitis.
    Awla D; Hartman H; Abdulla A; Zhang S; Rahman M; Regnér S; Thorlacius H
    Br J Pharmacol; 2011 Feb; 162(3):648-58. PubMed ID: 20942858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of different protein tyrosine kinases in fMLP-induced neutrophil transmigration.
    Zen K; Liu Y
    Immunobiology; 2008; 213(1):13-23. PubMed ID: 18207024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo toxicity and antithrombotic profile of the oral formulation of the antileukemic agent, LFM-A13-F.
    Tibbles HE; Samuel P; Erbeck D; Mahajan S; Uckun FM
    Arzneimittelforschung; 2004; 54(6):330-9. PubMed ID: 15281619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.